Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Shelter Pharma Ltd

Your Vote -

Buy

40.00%

Hold

20.00%

Sell

40.00%

40.00%

5 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Shelter Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Shelter Pharma - Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements) Regulation 2015 -

    13 Mar 2026, 11:26AM Intimation under Regulation 30 of SEBI ( Listing Obligation and Disclousure Requirements) Regulation 2015 - Appointment of Investor Relations and Pub
  • Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 07, 2026

    12 Mar 2026, 5:11PM As of March 2026, 44.41% is owned by Indian Promoters and 55.59% by Public. <p align=justify> Top five Promoters holding highest number of shares of S
  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    12 Mar 2026, 1:01PM Intimation with regards to Shelter Pharma secured order from First Vet Veterinary Medicines Trading LLC, UAE pursuant to Regulation 30 of SEBI ( Listi
  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Conversion of Securities

    7 Mar 2026, 1:07PM Conversion of 2,79,000 Warrants into 2,79,000 Equity Shares
  • Shelter Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday, March 07, 2026

    7 Mar 2026, 1:06PM Conversion of 2,79,000 warrants in to 2,79,000 Equity Shares
  • Shelter Pharma Limited launches &lsquo;FitKick Pro&rsquo; nutraceutical powder in three flavours

    2 Feb 2026, 12:09PM Shelter Pharma Limited has expanded its nutraceutical portfolio with the launch of FitKick Pro, a new performance-focused health powder available in t
  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    2 Feb 2026, 11:52AM Shelter Pharma Limited Launch a new Products Fitkick Pro with Three Different Flavors
  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    27 Jan 2026, 12:41PM Intimation with Regards to Shelter Pharma Secured Order from Taha Drugs & Chemicals Co. Ltd Pursuant to Regulation 30 of SEBI (Listing Obligation and
  • Shelter pharma secures $141,600 export order from Taha Drugs & Chemicals

    23 Jan 2026, 12:10PM Shelter Pharma Limited has secured an export order worth USD 141,600 from Taha Drugs & Chemicals Co. Ltd., Sudan, the company said in a regulatory fil
  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    23 Jan 2026, 12:03PM Intimation with Regards to \Shelter Pharma\ Secured Order from Taha Drugs & Chemicals Co. Ltd Pursuant to Regulation 30 of SEBI ( Listing Obligation a
  • Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    16 Dec 2025, 11:12AM Intimation with Regards to Shelter Pharma Secured Order from Taha Drugs & Chemicals Co. Ltd Pursuant to Regulation 30 of SEBI ( Listing Obligation and

Key fundamentals

Evaluate the intrinsic value of Shelter Pharma Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 43.7647 36.3931 16.2947 8.9366 7.1865
Liabilities 43.7647 36.3931 16.2947 8.9366 7.1865
Equity 11.5598 11.5598 7.7438 0.4839 0.4839
Gross Profit 10.0677 8.5714 8.0574 2.9223 0.1801
Net Profit 7.2374 6.2002 5.7833 1.8569 0.0509
Cash From Operating Activities 5.4822 -1.8502 0.0033 0 0
NPM(%) 14.28 15.49 15.99 6.17 0.22
Revenue 50.6602 40.0229 36.1527 30.0554 22.4834
Expenses 40.5925 31.4515 28.0953 27.1331 22.3032
ROE(%) 13.93 11.93 11.13 3.57 0.09

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Shelter Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 675.00 -0.72 40.03 18.84 301.39 0.74
Lotus Eye Hospital and Institute Ltd 106.95 1.57 345.74 68.65 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 16.28 -3.78 0.00 142.54 -39.50 0.00
Astec Lifesciences Ltd 581.00 -6.96 0.00 64.74 -604.75 0.00

Company Info

The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.

The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.

Read More

Parent Organisation

Shelter Pharma Ltd.

Founded

12/10/2007

Managing Director

Mr.Mustaqim Nisarahmed Sabugar

NSE Symbol

FAQ

The current price of Shelter Pharma Ltd is

The 52-week high for Shelter Pharma Ltd is

The market capitalization of Shelter Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Shelter Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Shelter Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shelter Pharma Ltd shares.

The CEO of Shelter Pharma Ltd is Mr.Mustaqim Nisarahmed Sabugar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT